Springer Healthcare news from the CTAD Conference

Catch up on the latest news and comments from the CTAD Conference with Springer Healthcare. 

Watch our experts discuss conference highlights, with Charlotte Teunissen, Craig Ritchie and Suzanne E Schindler.

Breakfast Bites

CTAD – Breakfast Bite 8 – Journey to a New Era in Alzheimer’s Disease

CTAD – Breakfast Bite 9 – Journey to a New Era in Alzheimer’s Disease

Read the latest news from the CTAD meeting

• Change to donanemab dosing could reduce ARIA-E rates
• Experts make recommendations on real-world donanemab use
• Real-world evidence supports ‘on label’ lecanemab use for patients with AD
• Discordant CSF/PET amyloid-β result signals need for follow-up before treatment
• Off-target vascular amyloid binding may not explain differences in ARIA-E rates